Novaliq Gmbh

Kirsten Eickhoff

Frank Löscher

Bernhard Günther

Diana Strehl

Markus Beier

Hartmut Voss

Sonja Krösser

Thomas Schlüter

Daniela Willen

Frank Loscher

Sonja Krosser

Thomas Schluter

Bernhard Gunther

The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein the composition comprises tafluprost and a semifluorinated alkane.

Ophthalmic compositions comprising tafluprost for the treatment of glaucoma

The present disclosure provides methods of treatment using ophthalmic compositions comprising semifluorinated alkanes for keratoconjunctivitis sicca and/or Meibomian gland dysfunction, which methods provide for the enrichment of an ophthalmic tissue in the semifluorinated alkane, and optionally methods of delayed release of the semifluorinated alkane from the enriched ophthalmic tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.

Opthalmic compositions comprising F6H8

The invention provides a pharmaceutical composition for use in the prevention or therapy of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith, wherein&#x2014;the composition comprises latanoprost and a liquid vehicle comprising a semifluorinated alkane; and&#x2014;the composition is administered to the eye of a subject; and&#x2014;the amount of latanoprost administered in a single dose per eye is in the range of from about 0.5 to 1.4 &#x3bc;g.

Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases

The present invention relates to pharmaceutical compositions comprising the selective beta 1 (B1)-receptor blocker nebivolol and/or a pharmaceutically acceptable salt thereof and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention is useful for topical administration, for example ophthalmic topical administration and for use in the treatment of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith.

Pharmaceutical compositions comprising nebivolol

Growing community of inventors

Aschaffenburg, Germany

Kirsten Eickhoff